文献速递骨软组织肉瘤与黑色素瘤头颈与中枢神经肿瘤支持与姑息治疗

儿童实体瘤转移灶根治性放疗:欧洲方案综述与SIOPE多中心调查

Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey.
PubMed 文献 · Eur J Cancer · 2021-01-16

该调查回顾了8项欧洲儿童实体瘤方案中对转移灶(骨、脑、远处淋巴结、肺、肝)的放疗推荐,并邀请年放疗≥50例儿童的SIOPE中心参与在线调查。所有方案均推荐对至少一个转移灶行放疗(高危神经母细胞瘤除外),但剂量、勾画和计划信息不一致;20/27中心完成调查,约14%患儿诊断时即有远处转移,其中半数以治愈为目的治疗,半数中心无明确转移灶数量上限,常规分割最常见。结论认为现行指南难以在多中心实现一致方法,需前瞻性随机试验。

要点

  • 所有方案推荐至少一个转移灶放疗,高危神经母细胞瘤除外。
  • 方案间剂量按部位各异,勾画与计划/实施信息普遍缺失。
  • 约14%患儿诊断时有远处转移,其中半数以治愈为目的放疗。

核心结论

  • 现行儿童实体瘤远处转移放疗指南无法在多中心环境下实现一致方法,需前瞻性随机试验明确根治性放疗作用。

研究设计与样本

  • 综述8项欧洲方案(横纹肌肉瘤、非横纹肌肉瘤软组织肉瘤、尤文肉瘤、神经母细胞瘤、肾肿瘤)对骨、脑、远处淋巴结、肺、肝转移灶的放疗推荐。
  • 邀请年放疗≥50例儿童的SIOPE中心参与在线调查,2019年7月至9月共20/27中心完成。

主要发现

  • 所有方案均推荐对至少一个转移灶行放疗,高危神经母细胞瘤除外。
  • 按方案剂量处方因部位而异,勾画及治疗计划/实施信息普遍缺失。
  • 调查中心中约14%患儿诊断时即有实体瘤远处转移,其中半数以治愈为目的治疗。
  • 半数中心未使用明确的转移灶最大数量截断值。
  • 无论肿瘤类型和部位,常规放疗方案最常用于治疗远处转移;使用立体定向放疗时分割方案范围广泛。

关键数值与推荐

  • 所有方案推荐至少一个转移灶放疗,高危神经母细胞瘤除外。
  • 约14%患儿诊断时有远处转移,其中半数以治愈为目的治疗。
  • 半数中心无明确转移灶最大数量截断值。
  • 常规放疗方案最常用于远处转移,立体定向放疗分割方案范围广泛。

临床怎么用

  • 在多中心临床实践中,转移灶放疗的剂量、勾画和计划需统一规范以减少差异。
  • 对儿童实体瘤远处转移决定根治性放疗时,应参考所在方案对特定部位的推荐。
  • 高危神经母细胞瘤转移灶放疗不被现行方案推荐。

局限性

  • 证据关于儿童实体瘤远处转移根治性放疗稀疏且开放个人解读。
  • 调查仅20/27中心完成,非全部SIOPE中心。
  • 方案中勾画及治疗计划/实施信息普遍缺失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE/OBJECTIVE: About 20% of children with solid tumours (ST) present with distant metastases (DM). Evidence regarding the use of radical radiotherapy of these DM is sparse and open for personal interpretation. The aim of this survey was to review European protocols and to map current practice regarding the irradiation of DM across SIOPE-affiliated countries. MATERIALS/METHODS: Radiotherapy guidelines for metastatic sites (bone, brain, distant lymph nodes, lung and liver) in eight European protocols for rhabdomyosarcoma, non-rhabdomyosarcoma soft-tissue sarcoma, Ewing sarcoma, neuroblastoma and renal tumours were reviewed. SIOPE centres irradiating ≥50 children annually were invited to participate in an online survey. RESULTS: Radiotherapy to at least one metastatic site was recommended in all protocols, except for high-risk neuroblastoma. Per protocol, dose prescription varied per site, and information on delineation and treatment planning/delivery was generally missing. Between July and September 2019, 20/27 centres completed the survey. Around 14% of patients were deemed to have DM from ST at diagnosis, of which half were treated with curative intent. A clear cut-off for a maximum number of DM was not used in half of the centres. Regardless of the tumour type and site, conventional radiotherapy regimens were most commonly used to treat DM. When stereotactic radiotherapy was used, a wide range of fractionation regimens were applied. CONCLUSION: Current radiotherapy guidelines for DM do not allow a consistent approach in a multicentre setting. Prospective (randomised) trials are needed to define the role of radical irradiation of DM from paediatric ST.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Huijskens SC, Kroon PS, Gaze MN, et al. Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey. Eur J Cancer. 2021. PMID: 33461061. doi:10.1016/j.ejca.2020.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。